Artículos por temáticas

[Assessment of benefits of drug therapies: memantine for Alzheimer's disease as an example]

Rüther E, Hellweg R, Janetzky W.

Fortschr Neurol Psychiatr. 2012 Dec;80(12):694-9. doi: 10.1055/s-0032-1312976. Epub 2012 Dec 10.

Increased cerebral metabolism after 1 year of deep brain stimulation in Alzheimer disease

Smith GS, Laxton AW, Tang-Wai DF, McAndrews MP, Diaconescu AO, Workman CI, Lozano AM.

Arch Neurol. 2012 Sep;69(9):1141-8. doi: 10.1001/archneurol.2012.590.

[Melatonin agonist: a possible disease-modifying agent for Alzheimer's disease]

Matsubara E.

Nihon Rinsho. 2012 Feb;70(2):349-52.

A reminiscence program intervention to improve the quality of life of long-term care residents with Alzheimer's disease: a randomized controlled trial

Serrani Azcurra DJ.

Braz J Psychiatry. 2012 Dec;34(4):422-33. doi: 10.1016/j.rbp.2012.05.008.

The effects of ramipril in individuals at risk for Alzheimer's disease: results of a pilot clinical trial

Wharton W, Stein JH, Korcarz C, Sachs J, Olson SR, Zetterberg H, Dowling M, Ye S, Gleason CE, Underbakke G, Jacobson LE, Johnson SC, Sager MA, Asthana S, Carlsson CM.

J Alzheimers Dis. 2012;32(1):147-56. doi: 10.3233/JAD-2012-120763.

[Nutritional factors in prevention of Alzheimer's disease]

Wyka J.

Rocz Panstw Zakl Hig. 2012;63(2):135-40.

Alzheimer's disease multiple intervention trial (ADMIT): study protocol for a randomized controlled clinical trial

Callahan CM, Boustani MA, Schmid AA, Austrom MG, Miller DK, Gao S, Morris CS, Vogel M, Hendrie HC.

Trials. 2012 Jun 27;13:92. doi: 10.1186/1745-6215-13-92.

Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab

Ostrowitzki S, Deptula D, Thurfjell L, Barkhof F, Bohrmann B, Brooks DJ, Klunk WE, Ashford E, Yoo K, Xu ZX, Loetscher H, Santarelli L.

Arch Neurol. 2012 Feb;69(2):198-207. doi: 10.1001/archneurol.2011.1538. Epub 2011 Oct 10.

Effect of some medicinal plant extracts on the oxidative stress status in Alzheimer's disease induced in rats

Mahdy K, Shaker O, Wafay H, Nassar Y, Hassan H, Hussein A.

Eur Rev Med Pharmacol Sci. 2012 Jul;16 Suppl 3:31-42.

Practical lessons from amyloid immunotherapy trials in Alzheimer disease

Solomon A, Akenine U, Andreasen N, Mangialasche F, Wimo A, Jelic V, Kivipelto M, Winblad B.

Curr Alzheimer Res. 2012 Dec;9(10):1126-34. doi: 10.2174/156720512804142958.

Natural compounds that modulate BACE1-processing of amyloid-beta precursor protein in Alzheimer's disease

Zhang C.

Discov Med. 2012 Sep;14(76):189-97.

Current concepts on selected plant secondary metabolites with promising inhibitory effects against enzymes linked to Alzheimer's disease

Orhan IE.

Curr Med Chem. 2012;19(14):2252-61. doi: 10.2174/092986712800229032.

Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD, and wild-type mice

Masciopinto F, Di Pietro N, Corona C, Bomba M, Pipino C, Curcio M, Di Castelnuovo A, Ciavardelli D, Silvestri E, Canzoniero LM, Sekler I, Pandolfi A, Sensi SL.

Cell Death Dis. 2012 Dec 20;3(12):e448. doi: 10.1038/cddis.2012.189.

The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design

Andersen F, Viitanen M, Halvorsen DS, Straume B, Wilsgaard T, Engstad TA.

BMC Neurol. 2012 Jul 19;12:59. doi: 10.1186/1471-2377-12-59.

[Montessori method applied to dementia - literature review]

Brandão DF, Martín JI.

Rev Gaucha Enferm. 2012 Jun;33(2):197-204. doi: 10.1590/s1983-14472012000200027.